Resonant
Chad Pollard is a highly skilled biotechnology professional with extensive experience in leadership and data analysis within the field. Currently serving as Co-Founder and CEO of Renew Biotechnologies since June 2022, Chad is also Co-Founder of Resonant and CEO of Wasatch Biolabs, both launched in 2023. Previously, Chad held the position of Data Scientist at Inherent Biosciences, Inc. from June 2021 to May 2022, where responsibilities included analyzing DNA methylation data sets to enhance epigenetic diagnostics for men's fertility. Academic credentials include a Doctor of Philosophy in Cell Biology and Physiology from Brigham Young University, anticipated in April 2025, and a degree in Genetics Genomics and Biotech, focusing on Epigenetics, obtained in 2022 from the same institution.
This person is not in any teams
Resonant
Neurodegenerative disorders (NGDs) affect millions worldwide. Starting with Alzheimers, we are committed to creating novel testing solutions for early detection to provide clinicians, researchers, and individuals with the tools to effectively diagnose, treat, and manage NGDs.